Russian NGOs fear fate of HIV harm-reduction programs as planned exit of Global Fund occurs

NewsGuard 100/100 Score

The Moscow Times examines a potential shift in Russia's public health priorities as programs funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria begin to phase out. "While the Global Fund's eight-year presence in Russia was long expected to end, officials with regional non-governmental organizations (NGOs) largely dependent on the group's financing say the country is now turning its back on widely accepted harm-reduction strategies and will let independent HIV-prevention groups wither and die," the newspaper writes.

"In the wake of the Global Fund's exit, the Russian government assumed full responsibility for funding the prevention and treatment of HIV/AIDS and has pledged more money than ever accordingly," but "[p]rograms such as handing out condoms to sex workers, needle exchanges and methadone treatments that are internationally seen as successful methods to prevent the spread of HIV have been frowned upon or outright banned in Russia, where health officials argue they fuel drug-taking and other risky behavior that breeds higher infection rates," according to the newspaper. "Health experts and NGOs agree that a change in strategy is needed if Russia is to come up with an effective response to its HIV epidemic," the newspaper writes (Winning, 2/15).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication